# Eptifibatide

NDC: 0338-9558
Generic name: Eptifibatide
Labeler / Manufacturer: Baxter Healthcare Company
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION
Routes: INTRAVENOUS
Marketing started: 20190201

FDA application: ANDA208554

## Active ingredients

- EPTIFIBATIDE: 75 mg/100mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0338-9558"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0338-9558
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5f46b76b-5c83-49b9-ada8-4ad5cf81a38c